Community Research and Development Information Service - CORDIS

  • European Commission
  • Projects and Results
  • Periodic Reporting for period 1 - INNOLABS (INNOvative LABS for leveraging cross capacity building between ICT, Health, BIO and Medicine sectors for new emerging industries in personalized health)

INNOLABS Report Summary

Project ID: 691556
Funded under: H2020-EU.2.3.2.

Periodic Reporting for period 1 - INNOLABS (INNOvative LABS for leveraging cross capacity building between ICT, Health, BIO and Medicine sectors for new emerging industries in personalized health)

Reporting period: 2017-01-01 to 2018-03-31

Summary of the context and overall objectives of the project

The INNOLABS project aims to foster collaboration, transfer of knowledge and opportunities among SMEs from different countries and sectors in order to develop, improve and deliver disruptive technologies mainly related to mHealth, personalized healthcare and ageing populations. The project aims at studying the market dynamics and specificities for innovations created by merging ICT and biomedical research and try to find out what really helps SMEs to get the innovative products/services created by combining different value chains to market fast while also being able to adapt to changing end-user needs.
Part of this challenge is about engaging end-users in shaping product development and using expert platforms with beta-testers in time limited cross-sectorial value chains:
the development of a new value chain is often driven by a disruptive idea or the convergence of existing ideas, again in different places. New value chains are like DNA chains that create new values by connecting new solutions with each other. The increasing speed of change means that new value chains emerge quickly and have a shorter lifetime than the old ones .
The main outcome of the INNOLABS project will be a catalogue of monetary and non-monetary measures provided by regional innovation clusters to support SMEs to deliver timely and innovative products and services thereby increasing the competitiveness of SMEs and advancing the positioning of European regions in these new emerging markets.
The following objectives provide the keys to unlocking the potential of SMEs:
1. Test and validate optimal support measures for taking merged ICT and biomedical research products and services to market by comparing measures for traditional value chains with new fast lane measures.
2. Increase the competitiveness of SMEs by using targeted non-monetary support mechanisms that generate added value encompassing expert knowledge, new partnerships and market optimisation of products.
3. Secure new funding streams to facilitate sustainable cycles of collaborative IHBM innovation by SMEs.

Work performed from the beginning of the project to the end of the period covered by the report and main results achieved so far

In doing this, the INNOLABS consortium has conducted a large number of activities to, first, generate momentum around the project’s objectives, SME collaboration and project ideas; and second, support team formation and crystallization of ideas into projects to be submitted to the INNOLABS Open Calls. Among many other side events, one Idea Competition (in Barcelona) and 2 Hackathons (Gdansk and Oslo) took place during the first reporting period to which 85 SMEs were selected to participate.
Further, many of the participants and prize winners of those events, prepared proposals and submitted them to the 1st INNOLABS Open Call which received 117 applications. Out of those, the 50 best were selected and are currently being supported in the 1st INNOLABS Acceleration period with a range of services by the consortium and by external providers. Only the first 3 months of the acceleration period have elapsed during the 1st reporting period so, it is still early days but it starts becoming clear that this support is making a clear difference for many of the SMEs engaged.

Progress beyond the state of the art and expected potential impact (including the socio-economic impact and the wider societal implications of the project so far)

The consortium is keeping track and closely monitoring the effects of the different types of support and services provide to SMEs and fine-tuning it to arrive at a cohesive and effective service package to gear up SMEs for the market challenges they face.
Further events engaging teams of SMEs and entrepreneurs are taking place in Berlin, Paris, Salamanca and Oslo, to ramp up ideas for the second INNOLABS Open Call, scheduled to launch in May 2018. In total, INNOLABS will support directly over 100 SMEs in bringing innovative technology to the market.

Related information

Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top